Research

Eisai/Biogen to advance Alzheimer’s drug, provide fresh hope

Read more

US FDA approves Krintafel for radical cure of P. vivax malaria

Read more

Verseon presents anticancer drug candidates targeting multidrug resistant cancers

Read more

Helperby Therapeutics announces phase 1 results demonstrating multiple benefits of its unique combination antibiotic therapy

Read more

Lupin’s steady stride on biosims

Read more

Berry pigments can open new avenues for cancer treatment

Read more

Lesaffre Human Care launches scientific papers on women’s health

Read more

Failure of the antimicrobials: A crisis at the door-step

Read more

YLB’s phase III clinical trial of Etanercept biosimilar meets positive outcome

Read more

Cancer targeted with reusable ‘stinging nettle’ treatment

Read more